India’s active pharmaceutical ingredient exports grew 12% year-on-year in the first quarter, according to trade figures cited by industry associations.
Analysts link the increase to restocking by generic manufacturers in Europe and North America, alongside new supply contracts for oncology and cardiovascular APIs.
Regulators continue to emphasize quality agreements and traceability as volumes rise across key shipping lanes.
